MARKET

BIO

BIO

Bio Rad Labs Inc
NYSE
362.08
+5.83
+1.64%
Pre Market: 362.00 -0.08 -0.02% 06:44 08/13 EDT
OPEN
353.06
PREV CLOSE
356.25
HIGH
362.42
LOW
351.00
VOLUME
7
TURNOVER
0
52 WEEK HIGH
362.42
52 WEEK LOW
236.73
MARKET CAP
9.68B
P/E (TTM)
43.89
1D
5D
1M
3M
1Y
5Y
1D
Bio-Rad (BIO) Q2 2026 Earnings Call Transcript
The Motley Fool · 1d ago
Bio Rad Laboratories (BIO) Issues Flat Revenue Guidance, Is It Too Far Above Fair Value?
Simply Wall St · 1d ago
Don't Overlook Bio-Rad (BIO) International Revenue Trends While Assessing the Stock
NASDAQ · 2d ago
Weekly Report: what happened at BIO last week (0803-0807)?
Weekly Report · 3d ago
Bio Rad Laboratories (BIO) Stock Looks Priced Above Fair Value
Simply Wall St · 4d ago
Bio-Rad Laboratories Is Maintained at Outperform by RBC Capital
Dow Jones · 5d ago
Bio-Rad Laboratories Price Target Raised to $390.00/Share From $370.00 by RBC Capital
Dow Jones · 5d ago
RBC Capital Maintains Outperform on Bio-Rad Laboratories, Raises Price Target to $390
Benzinga · 5d ago
More
About BIO
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.

Webull offers Bio-Rad Laboratories, Inc. stock information, including NYSE: BIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BIO stock methods without spending real money on the virtual paper trading platform.